Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

Cyanide Poisoning Clinical Trial

Official title:

Hydroxycobalamin and Rural Emergency Medical Services Cyanide Exposure Patients: A Cost Analysis

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT01656616
• Other study ID #: IRB 4053X
• Status: Withdrawn
• Phase: N/A
• First received: August 1, 2012
• Last updated: May 16, 2017
• Start date: August 1, 2012
• Est. completion date: August 1, 2012

Study information

• Verified date: May 2017
• Source: Maine Medical Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The costs to a rural emergency medical services (EMS) system of a change from a traditional cyanide antidote kit to a kit containing hydroxocobalamin alone are currently unknown. The purpose of this study is to use current EMS data to calculate the costs to a rural EMS system associated with the adoption of a hydroxocobalamin protocol for the treatment of suspected cyanide exposure.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: August 1, 2012
• Est. primary completion date: August 1, 2012
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Included in Maine EMS database

• House Fire Victim

• Poisoning

Exclusion Criteria:

• No potential cyanide exposure

• Incomplete data available

Related Conditions & MeSH terms

• Cyanide Poisoning
• Emergencies
• Poisoning

Intervention

Drug:
• Cyanide antidote administration

Locations

Country	Name	City	State
United States	Maine Medical Center Department of Emergency Medicine	Portland	Maine

Sponsors (1)

Lead Sponsor	Collaborator
Maine Medical Center

Country where clinical trial is conducted

United States,